These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 22566536

  • 1. Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early development.
    Peters SA, Schroeder PE, Giri N, Dolgos H.
    Drug Metab Dispos; 2012 Aug; 40(8):1495-507. PubMed ID: 22566536
    [Abstract] [Full Text] [Related]

  • 2. Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models.
    Guest EJ, Rowland-Yeo K, Rostami-Hodjegan A, Tucker GT, Houston JB, Galetin A.
    Br J Clin Pharmacol; 2011 Jan; 71(1):72-87. PubMed ID: 21143503
    [Abstract] [Full Text] [Related]

  • 3. Metabolic-based drug-drug interactions prediction, recent approaches for risk assessment along drug development.
    Boulenc X, Barberan O.
    Drug Metabol Drug Interact; 2011 Jan; 26(4):147-68. PubMed ID: 22149659
    [Abstract] [Full Text] [Related]

  • 4. Critique of the two-fold measure of prediction success for ratios: application for the assessment of drug-drug interactions.
    Guest EJ, Aarons L, Houston JB, Rostami-Hodjegan A, Galetin A.
    Drug Metab Dispos; 2011 Feb; 39(2):170-3. PubMed ID: 21036951
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods.
    Grime KH, Bird J, Ferguson D, Riley RJ.
    Eur J Pharm Sci; 2009 Feb 15; 36(2-3):175-91. PubMed ID: 19013237
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Application of mechanism-based CYP inhibition for predicting drug-drug interactions.
    Zhou ZW, Zhou SF.
    Expert Opin Drug Metab Toxicol; 2009 Jun 15; 5(6):579-605. PubMed ID: 19466877
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?
    Gomez-Mantilla JD, Huang F, Peters SA.
    Clin Pharmacokinet; 2023 Mar 15; 62(3):457-480. PubMed ID: 36752991
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prediction of CYP3A-mediated drug-drug interactions using human hepatocytes suspended in human plasma.
    Mao J, Mohutsky MA, Harrelson JP, Wrighton SA, Hall SD.
    Drug Metab Dispos; 2011 Apr 15; 39(4):591-602. PubMed ID: 21212240
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions.
    McGinnity DF, Waters NJ, Tucker J, Riley RJ.
    Drug Metab Dispos; 2008 Jun 15; 36(6):1126-34. PubMed ID: 18356267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of clearance concepts and modeling techniques in the prediction of metabolic drug-drug interactions.
    Ito K, Sugiyama Y.
    Trends Pharmacol Sci; 2010 Aug 15; 31(8):351-5. PubMed ID: 20542578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.